2. Academic Validation
  3. Kuwanon G attenuates atherosclerosis by upregulation of LXRα-ABCA1/ABCG1 and inhibition of NFκB activity in macrophages

Kuwanon G attenuates atherosclerosis by upregulation of LXRα-ABCA1/ABCG1 and inhibition of NFκB activity in macrophages

  • Toxicol Appl Pharmacol. 2018 Feb 15:341:56-63. doi: 10.1016/j.taap.2018.01.007.
Xiao-Xiao Liu 1,  Xiao-Wen Zhang 2,  Kai Wang 3,  Xue-Ying Wang 3,  Wen-Long Ma 4,  Wei Cao 5,  Dan Mo 3,  Yang Sun 1,  Xiao-Qiang Li 6
Affiliations

Affiliations

  • 1 Department of Pharmacology, School of Pharmacy, Fourth Military Medical University, Xi'an, China; Key Laboratory of Gastrointestinal Pharmacology of Chinese Materia Medica of the State Administration of Traditional Chinese Medicine, Xi'an, China.
  • 2 Department of Natural Medicine & Institute of Materia Medica, School of Pharmacy, Fourth Military Medical University, Xi'an, China.
  • 3 Department of Pharmacology, School of Pharmacy, Fourth Military Medical University, Xi'an, China.
  • 4 Department of Neurosurgery, Tangdu Hospital, Fourth Military Medical University, Xi'an, China.
  • 5 Shaanxi Key Laboratory of Natural Products & Chemical Biology, School of Chemistry & Pharmacy, Northwest A&F University, Yangling, China.
  • 6 Department of Pharmacology, School of Pharmacy, Fourth Military Medical University, Xi'an, China; Key Laboratory of Gastrointestinal Pharmacology of Chinese Materia Medica of the State Administration of Traditional Chinese Medicine, Xi'an, China. Electronic address: xxqqli@fmmu.edu.cn.
PMID: 29355567 DOI: 10.1016/j.taap.2018.01.007
Abstract

Background: Atherosclerosis is characterized by chronic inflammation in vascular wall. Previous studies suggest that Kuwanon G (KWG) exerts anti-inflammatory activities. However, the effect of KWG on atherosclerosis remains unexplored.

Aims: To explore whether KWG affects macrophage foam cell formation in vitro and atherogenesis in vivo.

Methods: RAW 264.7 macrophages were stimulated with ox-LDL for 24h to induce foam cell formation and treated with KWG. Foam cell formation was determined by ORO staining and enzymatic analysis. Pro-inflammatory cytokines mRNA levels were tested by Real-Time PCR method. Further molecular mechanism was investigated using Western blot. In vivo, apoE-/- mice were fed with high-fat diet and intraperitoneally injected with KWG. Atherosclerotic lesion was accessed by H&E and ORO staining. Plaque composition was evaluated by immunohistochemistry and Sirius Red staining. Serum lipid profile and inflammatory cytokines were evaluated by enzymatic method and ELISA.

Results: KWG significantly decreased intracellular lipid accumulation and inflammatory cytokines mRNA levels in macrophages through enhancing LXRα-ABCA1/ABCG1 pathway and inhibiting NFκB activation. Administrated with KWG remarkably reduced the atherosclerotic lesion areas and macrophage content in the plaque of high-fat diet fed apoE-/- mice. KWG also reduced hyperlipidemia and serum inflammatory cytokines in vivo.

Conclusion: Taken together, these data highlight that KWG can attenuate atherosclerosis through inhibiting foam cell formation and inflammatory response.

Keywords

Atherosclerosis; Foam cell formation; Inflammatory; Kuwanon G; Macrophages.

Figures
Products